JP2020515598A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515598A5
JP2020515598A5 JP2019553439A JP2019553439A JP2020515598A5 JP 2020515598 A5 JP2020515598 A5 JP 2020515598A5 JP 2019553439 A JP2019553439 A JP 2019553439A JP 2019553439 A JP2019553439 A JP 2019553439A JP 2020515598 A5 JP2020515598 A5 JP 2020515598A5
Authority
JP
Japan
Prior art keywords
indylbin
solvent
derivative
pharmaceutically acceptable
acceptable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019553439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/025075 external-priority patent/WO2018183631A1/en
Publication of JP2020515598A publication Critical patent/JP2020515598A/ja
Publication of JP2020515598A5 publication Critical patent/JP2020515598A5/ja
Priority to JP2023000437A priority Critical patent/JP2023040147A/ja
Pending legal-status Critical Current

Links

JP2019553439A 2017-03-29 2018-03-29 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法 Pending JP2020515598A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023000437A JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762478317P 2017-03-29 2017-03-29
US62/478,317 2017-03-29
PCT/US2018/025075 WO2018183631A1 (en) 2017-03-29 2018-03-29 Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023000437A Division JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Publications (2)

Publication Number Publication Date
JP2020515598A JP2020515598A (ja) 2020-05-28
JP2020515598A5 true JP2020515598A5 (https=) 2021-05-06

Family

ID=63676834

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019553439A Pending JP2020515598A (ja) 2017-03-29 2018-03-29 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法
JP2023000437A Withdrawn JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023000437A Withdrawn JP2023040147A (ja) 2017-03-29 2023-01-05 インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法

Country Status (7)

Country Link
US (3) US20200016087A1 (https=)
EP (1) EP3600259A4 (https=)
JP (2) JP2020515598A (https=)
CN (2) CN115969814A (https=)
AU (1) AU2018244442A1 (https=)
CA (1) CA3058407A1 (https=)
WO (1) WO2018183631A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101855423B1 (ko) * 2017-04-18 2018-05-09 주식회사 씨케이바이오텍 인디루빈 유도체를 유효성분으로 포함하는 약학 조성물
MX2021012548A (es) * 2019-04-17 2023-01-05 Azora Therapeutics Inc Composiciones topicas y metodos para el tratamiento de enfermedades inflamatorias de la piel.
US12303490B2 (en) 2019-11-04 2025-05-20 Ck Regeon Inc. Compositions and methods for suppressing and/or treating neurodegenerative diseases and/or a clinical condition thereof
CN115175673A (zh) * 2020-02-26 2022-10-11 上海科技大学 双硫仑在抗冠状病毒中的应用
WO2022229985A1 (en) * 2021-04-29 2022-11-03 Jawaharlal Nehru Centre For Advanced Scientific Research Soluble analogues of 6bio thereof and implementation thereof
CN118317948A (zh) 2021-10-08 2024-07-09 阿佐拉治疗股份有限公司 芳烃受体激动剂的衍生物
CN114668744A (zh) * 2022-03-23 2022-06-28 成都大学 一种靛玉红固体脂质纳米粒及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686988A1 (en) * 2003-10-28 2006-08-09 The Rockefeller University Indirubin-type compounds, compositions, and methods for their use
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
WO2012135813A1 (en) * 2011-03-31 2012-10-04 University Of Rochester Methods and compositions for mesenchymal stem cell proliferation
US9707186B2 (en) * 2012-02-21 2017-07-18 Amrita Vishwa Vidyapeetham Core-shell particle formulation for delivering multiple therapeutic agents
WO2013124867A1 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules
ES2685743T3 (es) * 2012-02-29 2018-10-11 Merck Patent Gmbh Procedimiento para la fabricación de nanopartículas cargadas con principio activo
EP2863897B1 (en) * 2012-06-21 2019-06-19 Phosphorex Inc. Nanoparticles of indirubin, derivatives thereof and methods of making and using same
WO2014152451A2 (en) * 2013-03-14 2014-09-25 University Of Rochester Compositions and methods for controlled localized delivery of bone forming therapeutic agents
CN103550206B (zh) * 2013-10-23 2015-11-25 重庆市中药研究院 一种白藜芦醇靛玉红组合药物、缓释微囊剂及其应用
EP2878312A1 (en) * 2013-12-02 2015-06-03 Albert-Ludwigs-Universität Freiburg Reversible PEGylation of nanocarriers
JP2017500343A (ja) * 2013-12-20 2017-01-05 フォスフォレックス，インコーポレーテッド インジルビン固体分散体組成物
WO2016197262A1 (en) * 2015-06-12 2016-12-15 Bayer Pharma Aktiengesellschaft Process for the preparation of porous microparticles
JP2018523702A (ja) * 2015-08-17 2018-08-23 フォスフォレックス，インコーポレイテッド 分解性ポリマーの極小ナノ粒子

Similar Documents

Publication Publication Date Title
JP2020515598A5 (https=)
CN104136012B (zh) 制备装载有活性物质的纳米颗粒的方法
Li et al. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment
Ravi et al. Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation
Alhowyan et al. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies
Diab et al. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
Nguyen et al. Cost-effective alternative to nano-encapsulation: amorphous curcumin–chitosan nanoparticle complex exhibiting high payload and supersaturation generation
CN112472814A (zh) 神经活性类固醇制剂和治疗中枢神经系统障碍的方法
WO2014108076A1 (zh) 难溶性药物凝胶组合物及其制备方法
Sotoudegan et al. Nimodipine-loaded Pluronic® block copolymer micelles: preparation, characterization, in-vitro and in-vivo studies
US20240408050A1 (en) Dihydromyricetin spray-dried dispersion formulations and methods for forming them
Moghaddam et al. Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin
WO2006038552A1 (ja) 微粒子含有組成物およびその製造方法
CN100518831C (zh) 固体纳米药物及其制备方法
CN102370622A (zh) 一种载药物纳米粒及其制备方法和应用
CN106943379A (zh) 一种藤黄酸白蛋白纳米粒及其制备方法
CN107126426A (zh) 一种盐酸阿霉素自组装聚合物纳米粒及其制备方法
Yuan et al. pH‐driven entrapment of enrofloxacin in casein‐based nanoparticles for the enhancement of oral bioavailability
Sikwal et al. Non-ionic self-assembling amphiphilic polyester dendrimers as new drug delivery excipients
CN106852911B (zh) 一种稳定的卡巴他赛白蛋白组合物及其制备方法
WO2023187831A1 (en) A nano in micro formulation and process thereof
Patil et al. Solid Lipid Nanoparticles: A Review.
Gupta et al. Recent advances in the surfactant and controlled release polymer-based solid dispersion
Gómez-Gaete et al. Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles
CN108379241B (zh) 胆甾醇疏水改性普鲁兰-多奈哌齐-聚山梨酯80纳米粒子及制备和应用